Trial
NCT03040427
The Role of F-18 Florbetapir in the Early Detection of Cardiac Amyloidosis
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
The Cleveland Clinic
Collaborators
Avid Radiopharmaceuticals
Condition
Cardiac Amyloidosis
Intervention
F-18 florbetapir
Why stopped
Low enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-07-27